Millis SZ - Search Results

1

Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options.

Ang C, Miura JT, Gamblin TC, He R, Xiu J, Millis SZ, Gatalica Z, Reddy SK, Yee NS, Abou-Alfa GK. Ang C, et al. Among authors: millis sz. J Surg Oncol. 2016 Jan;113(1):55-61. doi: 10.1002/jso.24086. Epub 2015 Dec 10. J Surg Oncol. 2016. PMID: 26661118

2

Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases.

Gatalica Z, Millis SZ, Vranic S, Bender R, Basu GD, Voss A, Von Hoff DD. Gatalica Z, et al. Among authors: millis sz. Oncotarget. 2014 Dec 15;5(23):12440-7. doi: 10.18632/oncotarget.2574. Oncotarget. 2014. PMID: 25415047 Free PMC article.

3

Multi-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets.

Movva S, Wen W, Chen W, Millis SZ, Gatalica Z, Reddy S, von Mehren M, Van Tine BA. Movva S, et al. Among authors: millis sz. Oncotarget. 2015 May 20;6(14):12234-47. doi: 10.18632/oncotarget.3498. Oncotarget. 2015. PMID: 25906748 Free PMC article.

4

Predictive Biomarker Profiling of > 6000 Breast Cancer Patients Shows Heterogeneity in TNBC, With Treatment Implications.

Millis SZ, Gatalica Z, Winkler J, Vranic S, Kimbrough J, Reddy S, O'Shaughnessy JA. Millis SZ, et al. Clin Breast Cancer. 2015 Dec;15(6):473-481.e3. doi: 10.1016/j.clbc.2015.04.008. Epub 2015 Apr 28. Clin Breast Cancer. 2015. PMID: 26051240 Free article.

5

Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors.

Millis SZ, Ikeda S, Reddy S, Gatalica Z, Kurzrock R. Millis SZ, et al. JAMA Oncol. 2016 Dec 1;2(12):1565-1573. doi: 10.1001/jamaoncol.2016.0891. JAMA Oncol. 2016. PMID: 27388585

6

PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation.

Joseph RW, Millis SZ, Carballido EM, Bryant D, Gatalica Z, Reddy S, Bryce AH, Vogelzang NJ, Stanton ML, Castle EP, Ho TH. Joseph RW, et al. Among authors: millis sz. Cancer Immunol Res. 2015 Dec;3(12):1303-7. doi: 10.1158/2326-6066.CIR-15-0150. Epub 2015 Aug 25. Cancer Immunol Res. 2015. PMID: 26307625 Free PMC article.

7

Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer.

Abbosh P, Sundararajan S, Millis SZ, Hauben A, Reddy S, Geynisman DM, Uzzo R. Abbosh P, et al. Among authors: millis sz. Eur Urol Focus. 2018 Dec;4(6):969-971. doi: 10.1016/j.euf.2017.01.003. Epub 2017 Jan 23. Eur Urol Focus. 2018. PMID: 28753842

8

Highlights from the latest findings in tumor molecular profiling.

Xiu J, Basu G, Russell K, Millis SZ. Xiu J, et al. Among authors: millis sz. Future Oncol. 2014 Dec;10(15):2413-5. doi: 10.2217/fon.14.189. Future Oncol. 2014. PMID: 25525849 No abstract available.

9

Clinical Benefit from Trametinib in a Patient with Appendiceal Adenocarcinoma with a GNAS R201H Mutation.

Ang C, Stollman A, Zhu H, Sarpel U, Scarborough B, Sahni G, Millis SZ. Ang C, et al. Among authors: millis sz. Case Rep Oncol. 2017 Jun 22;10(2):548-552. doi: 10.1159/000477562. eCollection 2017 May-Aug. Case Rep Oncol. 2017. PMID: 28868010 Free PMC article.

10

Molecular profiling of infiltrating urothelial carcinoma of bladder and nonbladder origin.

Millis SZ, Bryant D, Basu G, Bender R, Vranic S, Gatalica Z, Vogelzang NJ. Millis SZ, et al. Clin Genitourin Cancer. 2015 Feb;13(1):e37-49. doi: 10.1016/j.clgc.2014.07.010. Epub 2014 Aug 1. Clin Genitourin Cancer. 2015. PMID: 25178641 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters